Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors

Technology appraisal guidance
Reference number: TA407
Published: 28 September 2016

History

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 291 KB)

Published:

04 August 2016
Committee papers (PDF 13.58 MB)

Published:

04 August 2016

Invitation to participate

Final scope (PDF 102 KB)

Published:

04 December 2015
Final matrix (PDF 40 KB)

Published:

04 December 2015
Equality impact assessment (Scoping) (PDF 63 KB)

Published:

04 December 2015
NICE's response to comments on the draft scope and provisional matrix (PDF 108 KB)

Published:

04 December 2015

Draft scope for consultation (pre-referral) - January 2015

Draft scope for consultation (pre-referral) - January 2015 (PDF 110 KB)

Published:

17 July 2015

Provisional matrix (pre-referral) - January 2015

Provisional matrix (pre-referral) - January 2015 (PDF 40 KB)

Published:

17 July 2015